• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed

    3/10/21 4:16:24 PM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $MNK alert in real time by email
    SC 13D/A 1 buxton-mallinsc13da_031021.htm BUXTON-MALLINCKRODT SC 13D/A#1

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13D/A

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO § 240.13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO

    § 240.13d-2(a)

    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*

    Mallinckrodt plc
    (Name of Issuer)

     

    Ordinary shares, par value $0.20 per share
    (Title of Class of Securities)

     

    G5785G107
    (CUSIP Number)

     

    The Buxton Helmsley Group, Inc.

    1185 Avenue of the Americas, Floor 3

    New York, N.Y. 10036-2600

    Tel.: +1 (212) 561-5540

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
    March 10, 2021
    (Date of Event which Requires Filing of this Statement)

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ].

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent.

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 2 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Buxton Helmsley Holdings, Inc.
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    WC
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Michigan
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    0
    8 SHARED VOTING POWER
    1,225,535
    9 SOLE DISPOSITIVE POWER
    0
    10 SHARED DISPOSITIVE POWER
    1,225,535
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,225,535
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    1.4%1
    14 TYPE OF REPORTING PERSON (See Instructions)
    HC, CO
           

    __________________

    1 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 3 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    The Buxton Helmsley Group, Inc.
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    WC
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Michigan
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    0
    8 SHARED VOTING POWER
    1,225,535
    9 SOLE DISPOSITIVE POWER
    0
    10 SHARED DISPOSITIVE POWER
    1,225,535
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,225,535
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    1.4%2
    14 TYPE OF REPORTING PERSON (See Instructions)
    CO, IA
           

     

     

     

    __________________

    2 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

      

     

     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 4 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Alexander Parker
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    AF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    0
    8 SHARED VOTING POWER
    1,225,535
    9 SOLE DISPOSITIVE POWER
    0
    10 SHARED DISPOSITIVE POWER
    1,225,535
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,225,535
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    1.4%3
    14 TYPE OF REPORTING PERSON (See Instructions)
    HC, IN
           

     

    __________________

    3 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

      

     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 5 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Vladislav Dikii
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Russia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    970,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    970,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    970,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    1.1%4
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    4 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 6 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Thomas Gitter
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    WC
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    0
    8 SHARED VOTING POWER
    626,750
    9 SOLE DISPOSITIVE POWER
    0
    10 SHARED DISPOSITIVE POWER
    626,750
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    626,750
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.7%5
    14 TYPE OF REPORTING PERSON (See Instructions)
    IA, IN
           

    __________________

    5 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 7 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Hank Beinstein
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    0
    8 SHARED VOTING POWER
    241,689
    9 SOLE DISPOSITIVE POWER
    0
    10 SHARED DISPOSITIVE POWER
    241,689
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    241,689
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.3%6
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    6 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 8 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Janice J. O’Connor
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    69,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    69,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    69,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%7
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    7 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 9 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Roman Dontsov Valentinovich
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Russia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    135,212
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    135,212
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    135,212
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.2%8
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    8 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 10 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Alexander Koch
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Germany
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    120,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    120,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    120,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%9
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    9 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 11 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Alex Peter Wounlund
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Denmark
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    47,018
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    47,018
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    47,018
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%10
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    10 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 12 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    James Jonathan Josey
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    111,400
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    111,400
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    111,400
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%11
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    11 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 13 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Kimberly Tully
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    90,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    90,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    90,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%12
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    12 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 14 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Andrew Gruber
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    80,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    80,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    80,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%13
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    13 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 15 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Alexander Lugovoy
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Russia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    79,090
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    79,090
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    79,090
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%14
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    _________________

    14 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 16 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Richard Barry
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    72,285
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    72,285
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    72,285
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%15
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    15 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 17 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Zavolozhin Sergey Vladimirovich
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Russia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    67,413
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    67,413
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    67,413
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%16
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    16 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 18 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Victor Pardo
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    52,080
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    52,080
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    52,080
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%17
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    17 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 19 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Mary Dunne
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    39,347
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    39,347
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    39,347
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.0%18
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    18 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 20 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Petr Hofrek
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    38,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    38,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    38,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.0%19
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    19 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 21 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Chris Tichenor
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    24,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    24,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    24,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.0%20
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    20 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 22 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Israel Larraondo
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Spain
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    20,139
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    20,139
    10 SHARED VOTING POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    20,139
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.0%21
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    21 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 23 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Robert Kramer
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    20,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    20,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    20,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.0%22
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    22 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 24 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    David Lamb
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    17,632
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    17,632
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    17,632
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.0%23
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    23 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 25 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Daniliuk Kirill Vladimirovich
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Russia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    193,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    193,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    193,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.2%24
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    24 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 26 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Joan I. Barry Revocable Trust (Dtd. 12/13/13)
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    WC
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    93,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    93,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    93,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%25
    14 TYPE OF REPORTING PERSON (See Instructions)
    OO
           

    __________________

    25 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 27 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Yushenkova Olga Petrovna
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Russia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    77,699
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    77,699
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    77,699
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%26
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    26 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 28 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Vanik Petrosian
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    Russia
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    74,300
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    74,300
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    74,300
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%27
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    27 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 29 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    John V. Barry Revocable Trust (Dtd. 12/13/13)
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    WC
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    44,000
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    44,000
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    44,000
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%28
    14 TYPE OF REPORTING PERSON (See Instructions)
    OO
           

    __________________

    28 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

     

    CUSIP No. G5785G107 SCHEDULE 13D Page 30 of 46 Pages

     

    1 NAMES OF REPORTING PERSONS
    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
    Pradeep Vasudeva Kadambi
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

    (a)  [X]

    (b)  [   ]

    3 SEC USE ONLY
     
    4 SOURCE OF FUNDS (See Instructions)
    PF
    5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E)
                                                                      [   ]
    6 CITIZENSHIP OR PLACE OF ORGANIZATION
    USA
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    7 SOLE VOTING POWER
    101,900
    8 SHARED VOTING POWER
    0
    9 SOLE DISPOSITIVE POWER
    101,900
    10 SHARED DISPOSITIVE POWER
    0
    11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    101,900
    12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)
    [   ]
    13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
    0.1%29
    14 TYPE OF REPORTING PERSON (See Instructions)
    IN
           

    __________________

    29 Based upon 84,604,862 shares of Ordinary shares, par value $0.20 per share (“Shares”), of Mallinckrodt plc. (the “Issuer”) outstanding as of October 30, 2020, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 3, 2020.

     

     
     
     

    This Amendment No. 1 to Schedule 13D (“Amendment No. 1”) amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission by the Reporting Persons on March 5, 2021 (the “Schedule 13D”) relating to the Ordinary shares, par value $0.20 per share (the “Shares”), of Mallinckrodt plc (the “Issuer”). Except as specifically provided herein, this Amendment No. 1 does not modify any of the information previously reported on the Schedule 13D. Capitalized terms used but not otherwise defined in this Amendment No. 1 shall have the meanings ascribed to them in the Schedule 13D.

     

    Item 1. Security and Issuer

    Item 1 of Schedule 13D is hereby amended and restated in its entirety to read as follows:

    This Schedule 13D is being filed with respect to common shares issued by Mallinckrodt plc, whose principal executive offices are at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.

     

    Item 2. Identity and Background

     

    Item 2 of Schedule 13D is hereby amended and restated in its entirety to read as follows:

     

      (a)

    This Schedule 13D is being filed jointly pursuant to that certain Joint Filing Agreement filed herewith as Exhibit 99.1 by:

    ·        Buxton Helmsley Holdings, Inc. (“Holdings”)

    ·        The Buxton Helmsley Group, Inc. (“Buxton”)

    ·        Alexander Parker (“Parker”) and

    ·        The individual persons and entities listed below (collectively, the “Individual Members”):

    o   Vladislav Dikii

    o   Thomas Gitter

    o   Hank Beinstein

    o   Janice J. O’Connor

    o   Roman Dontsov Valentinovich

    o   Alexander Koch

    o   Alex Peter Wounlund

    o   James Jonathan Josey

    o   Pradeep Vasudeva Kadambi

    o   Kimberly Tully

    o   Andrew Gruber

    o   Alexander Lugovoy

    o   Richard Barry

    o   Zavolozhin Sergey Vladimirovich

    o   Victor Pardo

    o   Mary Dunne

    o   Petr Hofrek

    o   Chris Tichenor

    o   Israel Larraondo

    o   Robert Kramer

    o   David Lamb

    o   Daniliuk Kirill Vladimirovich

    o   Joan I. Barry Revocable Trust (Dtd. 12/13/13)

    Page 31 of 46 Pages

      

     

       

    o   Yushenkova Olga Petrovna

    o   Vanik Petrosian

    o   John V. Barry Revocable Trust (Dtd. 12/13/13)

     

    Together with Holdings, Buxton, and Parker, the Individual Members comprise a group within the meaning of Section 13(d)(3) of the Act.

         
      (b) The business address of Holdings, Buxton, and Parker is 1185 Avenue of the Americas, Floor 3, New York, N.Y.  10036-2600. Information regarding the Individual Members is set forth on Schedule A.
         
      (c) Buxton is the wholly-owned subsidiary of Holdings, a parent holding company. Buxton is a private asset management and financial services firm and a registered investment advisor. Buxton holds the Shares reported in this Schedule 13D in the accounts of Buxton’s discretionary clients. Parker is the sole control person of both Buxton and Holdings.  Parker holds the title of Director at Holdings and Senior Managing Director at Buxton. There are no other directors, officers, or control persons at Holdings or Buxton. Information regarding the Individual Members is set forth on Schedule A.
         
      (d) During the last five years, neither Holdings, Buxton, Parker, nor any of the Individual Members have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
         
      (e) During the last five years, neither Holdings, Buxton, Parker, nor any of the Individual Members have been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and became subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
         
      (f) Holdings and Buxton are Michigan corporations. Parker is a citizen of the United States of America. The citizenship of each Individual Member is set forth on Schedule A.

     

    Item 3. Source and Amount of Funds or Other Considerations

    Item 3 of Schedule 13D is hereby amended and restated in its entirety to read as follows:

    Funds for the purchase of the Shares reported herein were derived from available working capital of Buxton. Buxton purchased 510,936 Shares of the Issuer in open market purchases between January 12, 2021 and March 1, 2021 for a total of $162,503.38. Buxton made other purchases of the Shares previously, also via available working capital.

    The Reporting Persons collectively may be deemed to be the beneficial owner of, in the aggregate, 4,730,489 Shares. For the Individual Members, other than Thomas Gitter, the Joan I. Barry Revocable Trust (Dtd. 12/13/13), and the John V. Barry Revocable Trust (Dtd. 12/13/13), whose funding for the Shares was derived from available working capital, the source of funding for the Shares was personal funds of the respective Individual Member.

     

    Item 4. Purpose of Transaction

     

    Item 4 of Schedule 13D is hereby amended and restated in its entirety to read as follows:

    Page 32 of 46 Pages

     
     
     

     

    The Reporting Persons reserve the right, consistent with applicable law, to (i) acquire additional Shares and/or other equity, debt, notes, instruments or other securities (collectively, "Securities") of the Issuer (or its affiliates) in the open market or otherwise; (ii) dispose of any or all of their Securities in the open market or otherwise; and (iii) engage in any hedging or similar transactions with respect to the Securities. The Reporting Persons may engage in discussions with management or the Board of Directors of the Issuer concerning the business, operations, management, and future plans of the Issuer. Depending on various factors, including the Reporting Persons’ financial position and investment strategy, the price of the Shares, conditions in the securities markets, and general economic and industry conditions, the Reporting Persons may in the future take such actions they deem appropriate, including, without limitation, seeking Board representation, submitting shareholder proposals, calling for a special shareholder meeting, or calling for changes in the board of directors or management of the Issuer.

     

    On March 10, 2021, the Reporting Persons sent a letter via email (the “Letter”) to the Issuer. The Letter is filed herewith as Exhibit 99.2 to the Amendment No. 1.

     

    Item 5. Interest in Securities of the Issuer

     

    Item 5 of Schedule 13D is hereby amended and restated in its entirety to read as follows:

     

    (a) As of the time of this filing, Holdings, Buxton, and Parker own 1,225,535 Shares of the Issuer, or a 1.4% ownership interest of the Issuer’s Shares. Information regarding the Individual Members is set forth on Schedule B. Collectively, Holdings, Buxton, Parker, and the Individual Members own 4,730,489 Shares or a 5.6% ownership interest of the Issuer’s Shares.
       
    (b)

    Number of Shares as to which such person has:

     

    (i) Sole Voting Power:

    Each of Holdings, Buxton, and Parker has the sole power to vote or direct the vote over 0 Shares.

     

    (ii) Shared Voting Power:

    Holdings has the shared power to vote or direct the vote over 1,225,535 Shares.

    Buxton has the shared power to vote or direct the vote over 1,225,535 Shares.

    Parker has the shared power to vote or direct the vote over 1,225,535 Shares.

     

    (iii) Sole Dispositive Power:

    Each of Holdings, Buxton, and Parker has the sole power to dispose or direct the disposition of 0 Shares.

     

    (iv) Shared Dispositive Power:

    Holdings has the shared power to dispose or to direct the direct the disposition of 1,225,535 Shares.

    Buxton has the shared power to dispose or to direct the direct the disposition of 1,225,535 Shares.

    Parker has the shared power to dispose or to direct the direct the disposition of 1,225,535 Shares.

     

    Information regarding the voting and dispositive power of the Individual Members is set forth on Schedule B.

       

    Page 33 of 46 Pages

      

     

    (c)

    The following table sets forth all transactions with respect to the Shares effected during the past sixty (60) days by any of the Reporting Persons, inclusive of any transactions effected through 5:00 p.m., New York City time, on March 5, 2021.  Except as otherwise noted below, all such transactions were purchases of Shares effected in the open market, and the table includes commissions paid in per share prices.

     

     

    Reporting Person Date Shares Price of Security
    Buxton 1/8/2021 2,50030 0.233
    Buxton 1/8/2021 2,74631 0.23
    Buxton 1/12/2021 30,000 0.2212
    Buxton 1/12/2021 4,600 0.25
    Buxton 1/12/2021 200 0.25
    Buxton 1/14/2021 73,547 0.249092567
    Buxton 1/14/2021 3,530 0.249092567
    Buxton 1/14/2021 72,923 0.249092567
    Buxton 1/19/2021 85,000 0.24495935
    Buxton 1/19/2021 941 0.24499575
    Buxton 1/19/2021 19,446 0.24499575
    Buxton 1/19/2021 19,613 0.24499575
    Buxton 1/20/2021 4,150 0.2406
    Buxton 2/18/2021 1,800 0.423
    Buxton 2/22/2021 1,238 0.44
    Buxton 2/22/2021 6,606 0.431
    Buxton 2/22/2021 100 0.431
    Buxton 2/22/2021 2,500 0.44
    Buxton 2/22/2021 300 0.4402
    Buxton 2/22/2021 17,640 0.45
    Buxton 2/23/2021 2,383 0.415
    Buxton 2/23/2021 29 0.42
    Buxton 2/24/2021 1 0.445
    Buxton 2/24/2021 12 0.445
    Buxton 2/24/2021 6 0.445
    Buxton 2/24/2021 28,790 0.445
    Buxton 2/24/2021 14,949 0.445
    Buxton 2/24/2021 12 0.445
    Buxton 2/24/2021 6 0.449947714
    Buxton 2/24/2021 7,996 0.449947714
    Buxton 2/24/2021 15,398 0.449947714
    Buxton 2/24/2021 500 0.425
    Buxton 2/24/2021 1,200 0.427
    Buxton 2/24/2021 2,853 0.4299
    Buxton 2/24/2021 2,500 0.4348
    Buxton 2/24/2021 5,975 0.435
    Buxton 2/24/2021 3,500 0.4475
    Buxton 2/24/2021 2,500 0.4475

     

    __________________

    30 Sale of Shares.

    31 Sale of Shares.

     

     

    Page 34 of 46 Pages

      

     

    Reporting Person Date Shares Price of Security
    Buxton 2/24/2021 2,500 0.4475
    Buxton 2/24/2021 5,024 0.45
    Buxton 2/25/2021 16,600 0.41
    Buxton 2/25/2021 2,655 0.4111
    Buxton 2/25/2021 1,069 0.4081
    Buxton 2/25/2021 10,000 0.47
    Buxton 2/25/2021 1,000 0.4106
    Buxton 2/25/2021 1,000 0.413
    Buxton 2/26/2021 2,500 0.41
    Buxton 2/26/2021 2,500 0.41
    Buxton 2/26/2021 2,500 0.41
    Buxton 2/26/2021 164 0.41
    Buxton 2/26/2021 4,233 0.4099
    Buxton 2/26/2021 405 0.41
    Buxton 2/26/2021 1,336 0.41
    Buxton 2/26/2021 1,124 0.41
    Buxton 3/1/2021 5,172 0.4065
    Buxton 3/1/2021 4,804 0.41
    Buxton 3/1/2021 156 0.4
    Buxton 3/1/2021 900 0.405
    Buxton 3/1/2021 2,500 0.41
    Buxton 3/1/2021 2,500 0.41
    Buxton 3/1/2021 2,500 0.41
    Buxton 3/1/2021 2,500 0.4111
    Buxton 3/1/2021 2,550 0.43
    Thomas Gitter 1/12/2021 13,838 0.22
    Thomas Gitter 1/12/2021 3,000 0.2175
    Thomas Gitter 1/12/2021 3,162 0.2174
    Thomas Gitter 1/14/2021 8,755 0.24
    Thomas Gitter 1/14/2021 1,245 0.2399
    Thomas Gitter 1/22/2021 24,720 0.239
    Thomas Gitter 1/22/2021 13,280 0.238
    Kimberly Tully 1/4/2021 3,000 0.26
    Kimberly Tully 1/13/2021 2,000 0.26
    Kimberly Tully 1/13/2021 3,000 0.23
    Kimberly Tully 1/13/2021 1,625 0.23
    Kimberly Tully 1/13/2021 1,175 0.22
    Kimberly Tully 1/13/2021 3,000 0.22
    Kimberly Tully 1/20/2021 1,200 0.24
    Kimberly Tully 1/22/2021 1,600 0.24
    Kimberly Tully 1/23/2021 4,999 0.24
    Kimberly Tully 1/25/2021 4,999 0.24
    Kimberly Tully 1/25/2021 4,999 0.24
    Kimberly Tully 1/26/2021 4,000 0.23
    Kimberly Tully 1/26/2021 1,101 0.24
    Kimberly Tully 1/26/2021 3,856 0.23
    Kimberly Tully 1/26/2021 4,999 0.23
    Kimberly Tully 1/26/2021 4,999 0.23

     

     

     

    Page 35 of 46 Pages 

      

     

    Reporting Person Date Shares Price of Security
    Kimberly Tully 1/26/2021 4,999 0.24
    Kimberly Tully 1/26/2021 4,999 0.24
    Kimberly Tully 1/27/2021 4,999 0.26
    Kimberly Tully 1/27/2021 4,999 0.2399
    Kimberly Tully 1/27/2021 4,999 0.239
    Kimberly Tully 1/27/2021 4,999 0.238
    Kimberly Tully 1/27/2021 2,000 0.34
    Kimberly Tully 1/29/2021 650 0.61
    Kimberly Tully 2/5/2021 100 0.42
    Kimberly Tully 2/9/2021 500 0.44
    Kimberly Tully 2/13/2021 1,000 0.43
    Kimberly Tully 2/15/2021 1,000 0.47
    Kimberly Tully 2/24/2021 1,000 0.45
    Kimberly Tully 3/1/2021 3,000 0.42
    Janice J. O’Connor 1/29/2021 10,400 0.43
    Chris Tichenor 2/09/2021 4,000 0.48
    Chris Tichenor 2/09/2021 1,000 0.47
    Chris Tichenor 2/24/2021 5,000 0.45
    Chris Tichenor 2/24/2021 3,452 0.45
    Chris Tichenor 2/25/2021 5,000 0.43
    Chris Tichenor 2/25/2021 1,548 0.39

     

     

       
    (d) N/A.
       
    (e) N/A.

     

    Item 7. Material to Be Filed as Exhibits

     

    Item 7 of Schedule 13D is hereby amended and restated in its entirety to read as follows:

     

      1. Joint Filing Agreement
         
      2. Letter

     

     

    Schedule A

     

    Schedule A of Schedule 13D is hereby amended and restated in its entirety to read as follows:

     

     

    Page 36 of 46 Pages

     

     

     

     

      

     

     

    Name Principal Business Address or Residence Principal Occupation or Employment/ Principal Business Citizenship
    Vladislav Dikii Moscow, p. Pervomayskoe, Block 328, Bld. 96, bldg. 9

    Investor (Self-Employed)

     

    Russia
    Thomas Gitter 17 Parklawn Place, Madison, WI  53705 Retired USA
    Hank Beinstein

    8 Dogwood Lane, Larchmont, NY, 10538

     

    Partner and Portfolio Manager at Gagnon Securities, LLC

    Principal Business: Investment Management

    Address: 1370 6th Ave # 24, New York, NY 10019

    USA
    Janice J. O'Connor 12808 S. Outer Belt Road, Lone Jack, MO  64070 Retired USA
    Roman Dontsov Valentinovich 350005 Russia, Krasnodar, Alexandra Pokryshkina street 2 /2 apartment 416 Self-Employed Russia
    Alexander Koch Jakob-Kaiser-Str. 14A, D-49088 Osnabrueck, Germany Self-Employed Germany
    Alex Peter Wounlund Bredholtvej 8, 2650 Hvidovre, Denmark

    Key Account Manager at GlobalConnect

    Principal Business: Fiber Network

    Address: Havneholmen 6, 2450 Copenhagen, Denmark

    Denmark
    James Jonathan Josey 5319 Carolwood Drive, Jackson, MS  39211

    Deputy CFO at The Molpus Woodlands Group, LLC

    Principal Business: Timber Investment

    Address:

    858 North Street, Jackson, MS 39211

    USA

    Page 37 of 46 Pages

      

     

    Pradeep Vasudeva Kadambi

    2764 Tartus Dr., Jacksonville, FL 32246 USA

     

    Physician at Self-Employed.

    Principal Business: Medicine

     

    Address: 655 W. 8th Street, Jacksonville, FL 32209

    USA
    Kimberly Tully 4 South Deer Place, Hainesport, NJ  08036 Self-Employed Consultant USA
    Andrew Gruber

    215 Pleasant Street, Arlington MA 02476

     

    Engineer at Qualcomm

    Principal Business: Wireless Technology

    Address: 5775 Morehouse Drive, San Diego CA 92121

    USA
    Alexander Lugovoy Russia, Rostov of Don, Big Sadovaya Street 120 kv 35 Self-Employed Russia
    Richard Barry 4532 Saint James Drive, Plano TX  75024

    IT Management at United Surgical Partners Incorporated

    Principal Business: Ambulatory Surgery Services

    Address: 5601 Warren Parkway Frisco Texas, 75034

    USA
    Zavolozhin Sergey Vladimirovich Russia, Novosibirsk region, R, P Koltsovo 28

    Doctor at Self-Employed

    Principal Business: Medicine

    Address: Russia, Novosibirsk, Pasechnaya street 1, k 2

    Russia
    Victor Pardo 11 Threepence Drive, Melville, NY  11747

    Audio Engineer at Self-Employed

    Address: 1100 Haff Avenue, North Bellmore, NY 11710

    USA
    Mary Dunne 54 Hicks Street, Brooklyn, NY  11201 Retired USA

    Page 38 of 46 Pages

      

     

    Petr Hofrek 9516 Park Drive, Unit 206, Omaha, NE  68127

    Inventory Control at PAK Global LLC

    Principal Business: Industrial Fabrics and Hardware

    Address: 2528 South 156th Circle, Omaha, NE 68130

    USA
    Chris Tichenor 400 Redding Road, Lexington, KY  40517 Retired USA
    Israel Larraondo Medinaceli, 6, 6. 28660. Boadilla del Monte. Madrid. Spain

    Renewable Energy Technician at PEMOG

    Principal Business: Energy

    Address: Juan Carlos I. 31. 28660. Boadilla del Monte. Madrid. Spain.

    Spain
    Robert Kramer 136 Wesley Drive, Swedesboro, NJ  08085 Retired USA
    David Lamb 13560 NW Springville Road, Portland, OR  97229

    Digital Design Engineer at Skyworks Solutions, Inc.

    Principal Business: Semiconductors

    Address: 1600 NW Compton Drive, Suite 300, Hillsboro, OR 97006

    USA
    Daniliuk Kirill Vladimirovich 125315, G MOSKVA, PR-KT LENINGRADSKII, DOM 74/6, KV 76 Retired Russia
    Joan I. Barry Revocable Trust (Dtd. 12/13/13) 3313 S. Victoria Drive, Blue Springs, MO  64015 Retired USA
    Yushenkova Olga Petrovna Russia, Ryazan,Moscovskoe shosse d.33/4 kv.435 Investor (Self-Employed) Russia
    Vanik Petrosian Ul Vodopoinaia, d 19, kv 178, 357748, g Kislovodsk, Stavropolskii krai Retired Russia

    Page 39 of 46 Pages

      

     

    John V. Barry Revocable Trust (Dtd. 12/13/13) 3313 S. Victoria Drive, Blue Springs, MO  64015 Retired USA

     

     

     

    Schedule B

     

    Schedule B of Schedule 13D is hereby amended and restated in its entirety to read as follows:

     

     

    Name Aggregate Number of Shares Owned Percentage of Class Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power
    Vladislav Dikii 970,000 1.1% 970,000 0 970,000 0
    Thomas Gitter 626,750 0.7% 0 626,750 0 626,750
    Hank Beinstein 241,689 0.3% 0 241,689 0 241,689
    Janice J. O'Connor 69,000 0.1% 69,000 0 69,000 0
    Roman Dontsov Valentinovich 135,212 0.2% 135,212 0 135,212 0
    Alexander Koch 120,000 0.1% 120,000 0 120,000 0
    Alex Peter Wounland 47,018 0.1% 47,018 0 47,018 0
    James Jonathan Josey 111,400 0.1% 111,400 0 111,400 0
    Pradeep Vasudeva Kadambi 101,900 0.1% 101,900 0 101,900 0
    Kimberly Tully 90,000 0.1% 90,000 0 90,000 0
    Andrew Gruber 80,000 0.1% 80,000 0 80,000 0

    Page 40 of 46 Pages

      

     

    Alexander Lugovoy 79,090 0.1% 79,090 0 79,090 0
    Richard Barry 72,285 0.1% 72,285 0 72,285 0
    Zavolozhin Sergey Vladimirovich 67,413 0.1% 67,413 0 67,413 0
    Victor Pardo 52,080 0.1% 52,080 0 52,080 0
    Mary Dunne 39,347 0.0% 39,347 0 39,347 0
    Petr Hofrek 38,000 0.0% 38,000 0 38,000 0
    Chris Tichenor 24,000 0.0% 24,000 0 24,000 0
    Israel Larraondo 20,139 0.0% 20,139 0 20,139 0
    Robert Kramer 20,000 0.0% 20,000 0 20,000 0
    David Lamb 17,632 0.0% 17,632 0 17,632 0
    Daniliuk Kirill Vladimirovich 193,000 0.2% 193,000 0 193,000 0
    Joan I. Barry Revocable Trust (Dtd. 12/13/13) 93,000 0.1% 93,000 0 93,000 0
    Yushenkova Olga Petrovna 77,699 0.1% 77,699 0 77,699 0
    Vanik Petrosian 74,300 0.1% 74,300 0 74,300 0
    John V. Barry Revocable Trust (Dtd. 12/13/13) 44,000 0.1% 44,000 0 44,000 0

     

     

     

     

     

     

    Page 41 of 46 Pages

     
     
     

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    BUXTON HELMSLEY HOLDINGS, INC.    
         
         
    By: /s/ Alexander E. Parker   March 10, 2021
    Name: Alexander E. Parker    
    Title: Director    
         
         
         
    THE BUXTON HELMSLEY GROUP, INC.    
         
         
    By: /s/ Alexander E. Parker   March 10, 2021
    Name: Alexander E. Parker    
    Title: Senior Managing Director    
         
         
         
    ALEXANDER E. PARKER    
         
         
    By: /s/ Alexander E. Parker   March 10, 2021
    Name: Alexander E. Parker    
           
         
         
    VLADISLAV DIKII    
         
         
    By: */s/ Vladislav Dikii   March 10, 2021
    Name: Vladislav Dikii    
         
         
         
    THOMAS GITTER    
         
         
    By: */s/ Thomas Gitter   March 10, 2021
    Name: Thomas Gitter    
         
         
         

     

     

     

    Page 42 of 46 Pages

      

     

    HANK BEINSTEIN    
         
         
    By: */s/ Hank Beinstein   March 10, 2021
    Name: Hank Beinstein    
         
         
         
    JANICE J. O’CONNOR    
         
         
    By: */s/ Janice J. O’Connor   March 10, 2021
    Name: Janice J. O’Connor    
         
         
         
    ROMAN DONSTOV VALENTINOVICH    
         
         
    By: */s/ Roman Donstov Valentinovich   March 10, 2021
    Name: Roman Donstov Valentinovich    
         
         
         
    ALEXANDER KOCH    
         
         
    By: */s/ Alexander Koch   March 10, 2021
    Name: Alexander Koch    
         
         
         
    ALEX PETER WOUNLUND    
         
         
    By: */s/ Alex Peter Wounlund   March 10, 2021
    Name: Alex Peter Wounlund    
         
         
         
    JAMES JONATHAN JOSEY    
         
         
    By: */s/ James Jonathan Josey   March 10, 2021
    Name: James Jonathan Josey    
         
         
         
    PRADEEP VASUDEVA KADAMBI    
         
         
    By: */s/ Pradeep Vasudeva Kadambi   March 10, 2021
    Name: Pradeep Vasudeva Kadambi    
         
         
         

      

    Page 43 of 46 Pages 

      

     

    KIMBERY TULLY    
         
         
    By: */s/ Kimberly Tully   March 10, 2021
    Name: Kimberly Tully    
         
         
         
    ANDREW GRUBER    
         
         
    By: */s/ Andrew Gruber   March 10, 2021
    Name: Andrew Gruber    
         
         
         
    ALEXANDER LUGOVOY    
         
         
    By: */s/ Alexander Lugovoy   March 10, 2021
    Name: Alexander Lugovoy    
         
         
         
    RICHARD BARRY    
         
         
    By: */s/ Richard Barry   March 10, 2021
    Name: Richard Barry    
         
         
         
    ZAVOLOZHIN SERGEY VLADIMIROVICH    
         
         
    By: */s/ Zavolozhin Sergey Vladimirovich   March 10, 2021
    Name: Zavolozhin Sergey Vladimirovich    
         
         
         
    VICTOR PARDO    
         
         
    By: */s/ Victor Pardo   March 10, 2021
    Name: Victor Pardo    
         
         
         
    MARY DUNNE    
         
         
    By: */s/ Mary Dunne   March 10, 2021
    Name: Mary Dunne    
         
         
         

      

    Page 44 of 46 Pages 

      

     

    PETR HOFREK    
         
         
    By: */s/ Petr Hofrek   March 10, 2021
    Name: Petr Hofrek    
         
         
         
    CHRIS TICHENOR    
         
         
    By: */s/ Chris Tichenor   March 10, 2021
    Name: Chris Tichenor    
         
         
         
    ISRAEL LARRAONDO    
         
         
    By: */s/ Israel Larraondo   March 10, 2021
    Name: Israel Larraondo    
         
         
         
    ROBERT KRAMER    
         
         
    By: */s/ Robert Kramer   March 10, 2021
    Name: Robert Kramer    
         
         
         
    DAVID LAMB    
         
         
    By: */s/ David Lamb   March 10, 2021
    Name: David Lamb    
         
         
         
    DANILIUK KIRILL VLADIMIROVICH    
         
         
    By: */s/ Daniliuk Kirill Vladimirovich   March 10, 2021
    Name: Daniliuk Kirill Vladimirovich    
         
         
         
    JOAN I. BARRY REVOCABLE TRUST (DTD. 12/13/13)    
         
         
    By: */s/ Janice J. O’Connor   March 10, 2021
    Name: Janice J. O’Connor    
    Title: Co-Trustee    
         
         
         

     

    Page 45 of 46 Pages 

      

     

    YUSHENKOVA OLGA PETROVNA    
         
         
    By: */s/ Yushenkova Olga Petrovna   March 10, 2021
    Name: Yushenkova Olga Petrovna    
         
         
         
    VANIK PETROSIAN    
         
         
    By: */s/ Vanik Petrosian   March 10, 2021
    Name: Vanik Petrosian    
         
         
         
    JOHN V. BARRY REVOCABLE TRUST (DTD. 12/13/13)    
         
         
    By: */s/ Janice J. O’Connor   March 10, 2021
    Name: Janice J. O’Connor    
    Title: Co-Trustee    
         
         
         
    *By: /s/ Alexander E. Parker   March 10, 2021
    Name: Alexander E. Parker    
    Title: Attorney-in-Fact    

     

    Page 46 of 46 Pages

    Get the next $MNK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MNK

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $MNK
    SEC Filings

    View All

    Mallinckrodt plc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Mallinckrodt plc (0001567892) (Filer)

    11/5/21 6:01:46 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mallinckrodt plc filed SEC Form 8-K: Leadership Update

    8-K - Mallinckrodt plc (0001567892) (Filer)

    11/3/21 4:31:03 PM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by Mallinckrodt plc

    10-Q - Mallinckrodt plc (0001567892) (Filer)

    11/2/21 6:43:01 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $MNK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations

    Continuing to Serve Customers and Deliver High-Quality Therapies to Patients Without Interruption; Vendors and Suppliers to be Paid in Full in the Ordinary Course DUBLIN, Aug. 30, 2023 /PRNewswire/ -- Mallinckrodt plc (OTC:MNKTQ) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has received approvals from the U.S. Bankruptcy Court for the District of Delaware for its "First Day" motions related to the Company's voluntary Chapter 11 petitions filed on August 28, 2023. As expected, the Court granted Mallinckrodt approval to ac

    8/30/23 11:54:00 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations

    Initiates Voluntary Prepackaged Chapter 11 Proceedings with Overwhelming Support of Key Stakeholders, Including 85%+ of First and Second Lien Debtholders Continuing to Operate Normally, Serve Customers and Deliver High-Quality Therapies to Patients Vendors and Suppliers Expected to be Paid in Full in the Ordinary Course DUBLIN, Aug. 28, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has taken the next step to implement the comprehensive financial restructuring plan contemplated by a Restructuring Support Agreement ("RSA") the Company previously entered into with more than 85% of each of th

    8/28/23 12:17:00 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan

    Agreement Supported by a Substantial Majority of Each of its First and Second Lien Debtholders and Opioid Trust Financial Restructuring Plan to Significantly Reduce Debt, Increase Free Cash Flow Generation, Extend Maturity Runway and Better Position Company for Long-Term Success  Intends to Initiate Voluntary Prepackaged Chapter 11 Proceedings to Implement Plan Continuing to Deliver High-Quality Therapies to Patients and Serve Customers; Vendors and Suppliers to be Paid in Full in the Ordinary Course DUBLIN, Aug. 23, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced it has entered into a Restructur

    8/23/23 8:22:00 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $MNK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Norton David Y sold $1,334 worth of Ordinary Shares (5,080 units at $0.26), closing all direct ownership in the company

    4 - Mallinckrodt plc (0001567892) (Issuer)

    8/9/21 9:09:30 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: O'Neill Hugh M. sold $537 worth of Ordinary Shares (2,100 units at $0.26), decreasing direct ownership by 3% to 76,856 units

    4 - Mallinckrodt plc (0001567892) (Issuer)

    8/9/21 9:10:08 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4: A Kathy Schaefer disposed of $256 worth of Ordinary Shares (675 units at $0.38), decreasing direct ownership by 3% to 22,934 units

    4 - Mallinckrodt plc (0001567892) (Issuer)

    4/5/21 4:24:38 PM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $MNK
    Financials

    Live finance-specific insights

    View All

    Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year Guidance

    Advanced Launch of Terlivaz® with Rapid and Successful Uptake in Hospital Formulary Access and Continued Medical Community Interest Reports First Quarter Net Sales of $424.6 Million; Net Loss of $249.3 Million; Adjusted EBITDA of $123.5 Million; Diluted Loss Per Share of $18.93 and Adjusted Diluted Earnings Per Share of $1.68 Increased Cash on Hand to $480.0 Million and Reduced Exposure to Interest Rate Volatility Through Interest Rate Cap Agreement, Demonstrating Ongoing Focus on Disciplined Balance Sheet Management Reaffirmed 2023 Net Sales and Adjusted EBITDA Guidance Conference Call and Webcast Today at 8:30 a.m. ET DUBLIN, May 9, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK) ("Malli

    5/9/23 6:45:00 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mallinckrodt to Report Earnings Results for First Quarter 2023

    DUBLIN, April 24, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK), a global specialty pharmaceutical company, today announced that it will report first quarter 2023 earnings results for the period ended March 31, 2023, on Tuesday, May 9, 2023.  A conference call for investors will begin at 8:30 a.m. ET. The call can be accessed as follows: Live Call Participant Registration (including dial-in): https://register.vevent.com/register/BIbe1f9805fe5b4490acd8359f7bdd616dAudio Only Webcast Link (live and replay):https://edge.media-server.com/mmc/p/24fqexpxAt the Mallinckrodt website

    4/24/23 6:45:00 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance

    Made Solid Progress on Launch of Terlivaz® with Significant Medical Community Interest Appointed Chief Scientific Officer with Proven Record of Executing Clinical Programs and Advancing Product Development Pipelines Increased Cash on Hand to $409.5 Million, Underscoring Commitment to Strengthening Balance Sheet and Disciplined Approach to Cost Management Fiscal 2023 Guidance for Adjusted EBITDA is $510 Million to $560 Million Conference Call and Webcast Today at 8:30 a.m. ET DUBLIN, Feb. 28, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for the fourth quarter ended December 30, 2022. 

    2/28/23 6:45:00 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $MNK
    Leadership Updates

    Live Leadership Updates

    View All

    Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer

    DUBLIN, Jan. 12, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE:MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that Dr. Peter Richardson, B.Med.Sci., BM, BS, MRCP (UK) has been appointed Executive Vice President and Chief Scientific Officer, effective January 12, 2023. With more than 30 years of research and development experience in the pharmaceutical industry, Dr. Richardson will have executive responsibility for Mallinckrodt's branded research and development (R&D), medical affairs, safety, and regulatory affairs functions. He will serve on the Company's Executive Committee and succeeds Steven Romano, M.D., who departed Mallinckrodt in Dece

    1/12/23 6:45:00 AM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $MNK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Mallinckrodt plc (Amendment)

    SC 13D/A - Mallinckrodt plc (0001567892) (Subject)

    11/12/21 2:55:13 PM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D/A filed by Mallinckrodt plc (Amendment)

    SC 13D/A - Mallinckrodt plc (0001567892) (Subject)

    11/5/21 2:58:50 PM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D/A filed by Mallinckrodt plc (Amendment)

    SC 13D/A - Mallinckrodt plc (0001567892) (Subject)

    10/22/21 4:48:46 PM ET
    $MNK
    Biotechnology: Pharmaceutical Preparations
    Health Care